Mycophenolate mofetil for the treatment of chronic dermatitis: An open-label study of 16 patients

Journal of Drugs in Dermatology

Volumn 9, Issue 4, 2010, Pages 356-362

  Jackson, J Mark ^a   Fowler Jr , Joseph F ^a   Callen, Jeffrey P ^a   Lorenz, Douglas J ^b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ECZEMA; FEMALE; HUMAN; INSOMNIA; LEUKOCYTE COUNT; MALE; NAUSEA; OPEN STUDY; PANCREAS CARCINOMA; PATIENT ASSESSMENT; SIDE EFFECT; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; BODY SURFACE; CHRONIC DISEASE;

BODY SURFACE AREA; CHRONIC DISEASE; ECZEMA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID;

EID: 77953626887     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hood KA, Zarembski DG. Mycophenolate mofetil: A unique immunosuppressive agent. Am J Health Syts Pharm. 1997;54:285-294. (Pubitemid 27066433)
2. Lipsky JJ. Mycophenolate mofetil. Lancet. 1996:348:1357-1359. (Pubitemid 26383778)
3. Gelber AC, Nousari HC, Wigley FM. Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: A series of 4 cases. J Rheumatol. 2000;27:1542-1545. (Pubitemid 30354061)
4. Goyal S, Nousari HC. Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil. J Am Acad Dermatol. 2001;45:142-144. (Pubitemid 32655712)
5. Farley-Li J, Mancini AJ. Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil. Arch Dermatol. 2003;139:1121-1124. (Pubitemid 37128371)
6. Frieling U, Bonsmann G, Schwarz T, et al. Treatment of severe lichen planus with mycophenolate mofetil. J Am Acad Dermatol. 2003:49:1063-1066. (Pubitemid 37475478)
7. Grundmann-Kollmann M, Kortind HC, Behrens S, et al. Mycophenolate mofetil: A new therapeutic option in the treatment of blistering autoimmune diseases. J Am Acad Dermatol. 1999;40:957-960. (Pubitemid 29268927)
8. Nousari HC, Griffin WA, Anhalt GJ. Successful therapy for bullous pemphigoid with mycophenolate mofetil. J Am Acad Dermatol. 1998;39:497-498. (Pubitemid 28417393)
9. Nousari HC, Sragovich A, Kimyai-Asadi A, et al. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol. 1999;40:265-268. (Pubitemid 29072810)
10. Katz KH, Marks JG, Helm KF. Pemphigus foliaceus successfully treated with mycophenolate mofetil as a corticosteroid-sparing agent. J Am Acad Dermatol. 2000;42:514-515. (Pubitemid 30470365)
11. Megahed M, Schmiedeberg S, Becker J, Ruzicka T. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a corticosteroid-sparing agent. J Am Acad Dermatol. 2001;45:256-259. (Pubitemid 32729310)
12. Powell AM, Albert S, Al Fares S, et al. An evaluation of the usefulness of mycophenolate mofetil in pemphigus. Br J Dermatol. 2003;149:138-145. (Pubitemid 36966523)
13. Mimouni D, Anhalt GJ, Cummins DL, et al. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil. Arch Dermatol. 2003;139:739-742. (Pubitemid 36705940)
14. Geilen CC, Arnold M, Orfanos CE. Mycophenolate mofetil as a systemic antipsoriatic agent: Positive experience in 11 patients. Br J Dermatol. 2001;144:583-586. (Pubitemid 32232016)
15. Nousari HC, Lynch WL, Anhalt GJ. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. Arch Dermatol. 1998;134:1509-1511. (Pubitemid 29009248)
16. Koba DJ, Momouni D, Rencic A, Nousari HC. Mycophenolate mofetil may serve as a corticosteroid-sparing agent for sarcoidosis. Br J Dermatol. 2003;148:147-148.
17. Grumdmann-Kollmann M, Korting HC, Behrens S, et al. Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil. Br J Dermatol. 1999;141:175-177.
18. Neuber K, Swhwartz I, Itschert G, Dieck AT. Treatment of atopic eczema with oral mychopenolate mofetil. Br J Dermatol. 2000;143:385-391. (Pubitemid 30650410)
19. Pickenacker A, Luger TA, Schwarz T. Dyshidrotic eczema treated with mycophenolate mofetil. Arch Dermatol. 1998;134:378-379. (Pubitemid 28141633)
20. Nousari HC, Anhalt GJ Morison WL. Mycophenolate in psoralen-UV-A desensitization therapy for chronic actinic dermatitis. Arch Dermatol. 1999;135:1128-1129. (Pubitemid 29430515)
21. Shoji Y, Fukumura T, Kudo M. Effect of topical preparation of mycophenolate mofetil on experimental allergic contact dermatitis of guinea pigs induced by dinitroflurobenzene. J Pharm Pharmacol. 1994;46:643-646. (Pubitemid 24249351)
22. Grundmann-Kollmann M, Podda M, Oshsendorf F, et al. Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Arch Dermatol. 2001;137:870-873. (Pubitemid 32641646)
23. Hansen ER, Buus S, Deleuran M, Andersen KE. Treatment of atopic dermatitis with mycophenolate mofetil. Br J Dermatol. 2000;143:1324-326. (Pubitemid 32052781)
24. Benez A., G Fierlbeck. Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil. Br J Dermatol. 2001;144:638-639. (Pubitemid 32232035)